For glaucoma.
Brand Name(s): Cosopt
Generic Name: Dorzolamide/Timolol PF
Instructions
If you use contact lenses, remove the contacts before using the medicine. Wait 15 minutes after using the medicine before putting the contacts back on.
Keep the medicine at room temperature. Avoid heat and direct light.
Keep the medicine in the foil pouch until you are ready to use it.
If you forget to take a dose on time, take it as soon as you remember. If it is almost time for the next dose, do not take the missed dose. Return to your normal schedule. Do not take 2 doses at one time.
Tell your doctor and pharmacist about all your medicines. Include prescription and over-the-counter medicines, vitamins, and herbal medicines.
If you are using another eye medicine, wait at least 5 minutes before using the other medicine.
Cautions
Tell your doctor and pharmacist if you ever had an allergic reaction to a medicine.
Do not use the medication any more than instructed.
This medicine may cause blurry vision.
Wait several minutes for your vision to clear before driving, or operating machinery.
Tell the doctor or pharmacist if you are pregnant, planning to be pregnant, or breastfeeding.
If you have diabetes, this medicine may hide some signs of low blood sugar, such as fast heartbeat. Check your blood sugar regularly and for other signs of low blood sugar.
Do not share this medicine with anyone who has not been prescribed this medicine.
Side Effects
The following is a list of some common side effects from this medicine. Please speak with your doctor about what you should do if you experience these or other side effects.
- blurry vision
- burning or stinging
- discomfort in the eyes
- irritation of the eyes
- itching, redness or dryness of eyes
- changes in taste or unpleasant taste
- watering of the eyes
Call your doctor or get medical help right away if you notice any of these more serious side effects:
- dizziness
- cold hands or feet
- numbness or tingling in hands and feet
- headaches
- slow heartbeat
- eye pain or swelling
- symptoms of stroke (such as one-sided weakness, slurred speech, confusion)
- unusual or unexplained tiredness or weakness
- blurring or changes of vision
A few people may have an allergic reaction to this medicine. Symptoms can include difficulty breathing, skin rash, itching, swelling, or severe dizziness. If you notice any of these symptoms, seek medical help quickly.
Please speak with your doctor, nurse, or pharmacist if you have any questions about this medicine.
IMPORTANT NOTE: This document tells you briefly how to take your medicine, but it does not tell you all there is to know about it. Your doctor or pharmacist may give you other documents about your medicine. Please talk to them if you have any questions. Always follow their advice.
There is a more complete description of this medicine available in English. Scan this code on your smartphone or tablet or use the web address below. You can also ask your pharmacist for a printout. If you have any questions, please ask your pharmacist.
The display and use of this drug information is subject to Terms of Use.
More information about TIMOLOL/DORZOLAMIDE DROPS - OPHTHALMIC
Copyright(c) 2024 First Databank, Inc.
Selected from data included with permission and copyright by First DataBank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
Conditions of Use: The information in this database is intended to supplement, not substitute for the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment. The display and use of this drug information is subject to express Terms of Use.
